References
- Fawzi AA, Simonett JM, Purta P, Moss HE, Lowry JL, Deng HX, Siddique N, Sufit R, Bigio EH, Volpe NJ, Siddique T. Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:569–580.
- Volpe NJ, Simonett J, Fawzi AA, Siddique T. Ophthalmic manifestations of amyotrophic lateral sclerosis (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2015;113:T12[1–15].
- Simonett JM, Huang R, Siddique N, Farsiu S, Siddique T, Volpe NJ, Fawzi AA. Macular sub-layer thinning and association with pulmonary function tests in amyotrophic lateral sclerosis. Sci Rep 2016;6:29187.
- Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M, Balcer LJ, Galetta SL, Liu GT. Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 2012;314:97–101.
- Moss HE, Samelson M, Mohan G, Jiang QL. High and low contrast visual acuity are not affected in amyotrophic lateral sclerosis. PLoS ONE 2016;11:e0168714.
- Geller AM, Hudnell HK. Critical issues in the use and analysis of the Lanthony Desaturate Color Vision test. Neurotoxicol Teratol 1997;19:455–465.
- Farnsworth D-15 and Lanthony Test Instructions rev 1.7 http://www.richmondproducts.com/files/8113/1550/0538/FR_15_Farnsworth_and_LanthonyD15_Instructions_Rev_1.7_0506.pdf2006. Updated May 2006. Accessed April 11, 2017.
- Vingrys AJ, King-Smith PE. A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci 1988;29:50–63.
- Török B. Farnsworth D-15 and Lanthony D-15 Color Vision Test Scoring http://www.torok.info/colorvision/d15.htm2013. Accessed April 11, 2017.
- McCluskey L, Vandriel S, Elman L, Van Deerlin VM, Powers J, Boller A, Wood EM, Woo J, McMillan CT, Rascovsky K, Grossman M. ALS-Plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci 2014;345:118–124.
- Bassi CJ, Solomon K, Young D. Vision in aging and dementia. Optom Vis Sci 1993;70:809–813.
- Pieri V, Diederich NJ, Raman R, Goetz CG. Decreased color discrimination and contrast sensitivity in Parkinson’s disease. J Neurol Sci 2000;172:7–11.
- Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson’s disease. Clin Neuropharmacol 1998;21:289–295.
- Gundogan FC, Tas A, Altun S, Oz O, Erdem U, Sobaci G. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis. Indian J Ophthalmol 2013;61:100–103.
- Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, Mass M, Balcer LJ. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology 2005;64:992–995.
- Martinez-Lapiscina EH, Ortiz-Perez S, Fraga-Pumar E, Martinez-Heras E, Gabilondo I, Llufriu S, Bullich S, Figueras M, Saiz A, Sanchez-Dalmau B, Villoslada P. Colour vision impairment is associated with disease severity in multiple sclerosis. Mult Scler 2014;20:1207–1216.
- Zhao J, Dave SB, Wang J, Subramanian PS. Clinical color vision testing and correlation with visual function. Am J Ophthalmol 2015;160:547–552.e1.